LUIS MIGUEL
RUILOPE URIOSTE
Chercheur jusqu {1}
Novartis (Sweden)
Täby, SueciaPublications en collaboration avec des chercheurs de Novartis (Sweden) (6)
2008
-
Public health value of fixed-dose combinations in hypertension
Blood Pressure, Vol. 17, Núm. SUPPL. 1, pp. 5-14
2007
-
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial
Journal of Hypertension, Vol. 25, Núm. 7, pp. 1473-1479
2005
-
24-Hour ambulatory blood-pressure effects of valsartan & hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: A VAST sub-study
Blood Pressure Monitoring, Vol. 10, Núm. 2, pp. 85-91
-
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: The VAST study
Clinical Therapeutics, Vol. 27, Núm. 5, pp. 578-588
2000
-
Safety of the combination of valsartan and benazepril in patients with chronic renal disease
Journal of Hypertension, Vol. 18, Núm. 1, pp. 89-95
1999
-
Receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits
Hypertension, Vol. 34, Núm. 4 II, pp. 969-975